tirzepatide taken off shortage list Compounders protest as FDA removes is tirzepatide back on the
Description
As of January 2026, 13 states cover tirzepatide and other GLP-1 medications for weight loss
The answer is generally yes, as long as you maintain approximately weekly spacing going forward

The FDA signaled escalating enforcement, and on April 30, 2026, it proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list - the mechanism that governs which substances large-scale compounders may use - with a public comment period open through June 29, 2026
Microencapsulation Technology
That mental shortcut eliminates the need for a chart entirely for 10mg/mL vials